Brief: Can Fite Biopharma Findings Demonstrate Namodenoson Anti-Cancer And Protective Effect Mechanism
24/06/2024 12:16
June 24 (Reuters) - Can Fite Biopharma Ltd CANF.TA :
* CAN FITE BIOPHARMA LTD - FINDINGS DEMONSTRATE NAMODENOSON
ANTI-CANCER AND PROTECTIVE EFFECT MECHANISM IN THE LIVER
Source text for Eikon: ID:n0001213900-24-054980
Further company coverage: CANF.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Can Fite Biopharma
See all newsBrief: Corrected-Can Fite Biopharma Ltd Files For Offering Of Up To 6.6 mln Ordinary Shares By Selling Shareholders
Can-Fite BioPharma rises after longer-than-anticipated overall survival in ongoing liver cancer study
Can-Fite BioPharma reports longer-than-anticipated overall survival in ongoing liver cancer study
Brief: Can Fite Biopharma Can-Fite Submits Phase 2 Study Protocol For Piclidenoson In Lowe Syndrome
Can-Fite rises as skin drug study reaches interim analysis stage